Dexcom (($DXCM)) announced an update on their ongoing clinical study. Study Overview: The COMPASS Program, officially titled ‘Continuous ...
ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.
(NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Euan Ashley to its Board of Directors, effective October 24, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback